Thursday, March 6, 2014
Publication and contact
interspaced short palindromic repeats (CRISPR) genome editing to produce
genetically modified monkeys
Primate studies suggest
CRISPR could be used to develop genetically modified monkeys that model
disease. In single-cell cynomolgus monkey embryos, injection of a pool of
five single guide RNAs (sgRNAs) targeting peroxisome proliferation-activated
activating gene 1 (RAG1) and nuclear
receptor subfamily 0 group B member 1 (NR0B1)
9 (Cas9) mRNA resulted in embryos with
simultaneous disruptions in two target genes. In infant monkeys born after
embryos were transferred to female monkeys, umbilical cord, placenta and ear
puncture tissues from twin monkeys had the same genetic modifications in Pparg
and Rag1. Next steps include developing germline-modified monkeys
using the strategy.
Published online March 6, 2014
unavailable for licensing
Niu, Y. et al. Cell;
published online Jan. 30, 2014;
Contact: Jiahao Sha, Nanjing Medical University, Nanjing, China
Contact: Xingxu Huang, Model Animal Research Center of
Nanjing University, Nanjing, China
Contact: Weizhi Ji, Yunnan Key Laboratory of Primate
Biomedical Research, Kunming, China
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]